ArticleNeurosurgical review2025
Exploring factors behind Arginine-Vasopressine deficiency in endoscopic endonasal surgery for PitNET: a single-center analysis of 349 patients.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Utility of Postoperative Thyroid Hormone Levels in Predicting the Diagnosis of Adult Growth Hormone Deficiency in Patients Undergoing Surgery for Nonfunctioning Pituitary Neuroendocrine Tumor: A Pilot Study.International journal of endocrinology · 2026Article
- Predictors of delayed hyponatremia after endoscopic transsphenoidal surgery for non-functioning pituitary adenomas.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arginine-Vasopressine deficiency (AVP-D), formerly known as Central Diabetes Insipidus, is a well-known complication in surgery for sellar/parasellar masses. Although less frequent in endoscopic series than transcranial and microscopic transsphenoidal ones, AVP-D has been variably related to different factors. Focusing the work on pituitary Neuroendocrine Tumors (PitNET), all patients who were treated endoscopically at a single centre were retrospectively reviewed to analyze the occurrence of this complication. Patient's characteristics, radiological information, and operative data were collected for patients who underwent surgery for PitNET at the same Institution by a single surgeon in the period 2016-2022. AVP-D was diagnosed in the presence of new-onset hypotonic polyuria with or without hypernatremia and was defined persistent if required a treatment with desmopressine/DDAVP for more than 6 months. Out of 349 patients (mean age at surgery 57.5 years old) 44 (12.6%) developed AVP-D (25 transient and 19 permanent). Younger age, the presence of an intraoperative CSF leak, the maximum diameter of the lesion, its suprasellar extension (considering the presence of a visual deficit), consistency of the lesion (distinguishing 4 classes, soft, soft-fibrous, fibrous and fibrous-firm), the extent of resection and the functioning status showed some relationship at univariate analysis (p < 0.05) with this complication. Larger diameter and longer operative time were seen more frequently in permanent AVP-D. A more solid intraoperative consistency with the presence of adherences (class 4 vs. class 1, OR 11.14, 95%CI 1.20-103.4) and the appearance of an intraoperative CSF-leak (OR 8.27, 95%CI 3.92-17.47) maintained a statistical significance in the multivariate logistic regression, with an older age being a protective factor in developing this deficiency (OR 0.96, 95%CI 0.95-0.99). The recognition of factors that can predict the onset of AVP-D with a certain degree of accuracy enables the entire staff to pay greater attention to the patient at risk in the postoperative period, thus preventing AVP-D complications.
Indexed as
Identifiers
40423881What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.